Table 2.

CA.ME.LI.A population stratified by gender, BMI, and glucose tolerance

	Total Population	Men	Women	P Value
n	2,545*	1,251	1,294
NFG/NBW	1,039 (40.8%)	372 (29.7%) (14.5%)	667 (51.6%) (26.2%)	<0.0001
NFG/OWO	754 (29.6%)	395 (31.6%) (15.5%)	359 (27.7%) (14.0%)
IFG/NBW	183 (7.2%)	105 (8.4%) (4.1%)	78 (6.0%) (3.0%)
IFG/OWO	398 (15.7%)	269 (21.5%) (10.5%)	129 (10.0%) (5.1%)
DM/NBW	28 (1.1%)	15 (1.2%) (0.5%)	13 (1.0%) (0.5%)
DM/OWO	143 (5.6%)	95 (7.6%) (3.7%)	48 (1.9%) (3.7%)

The % was calculated on the total number of subjects in the group (column). For men and women columns, an additional % vs. the whole population is also reported on the left. BMI, body mass index; CA.ME.LI.A, CArdiovascular risks, MEtabolic syndrome, LIver and Autoimmune disease; DM, diabetes mellitus; IFG, impaired fasting glucose; NBW, normal body weight; NFG, normal fasting glucose; OWO, overweight-obese.

*Nine patients of the whole CA.ME.LI.A population were excluded from the analysis for the lack of data, either BMI or glucose tolerance.